Scientist II - Principal Investigator
KCAS Bio
Olathe, Kansas
Amritangshu Chakravarty is a Scientist and Principal Investigator at KCAS Bio, a prominent bioanalytical contract research organization. He leads a team dedicated to developing mass spectrometry-based bioanalytical assays for various novel therapeutic modalities. His expertise covers small molecules, peptides, monoclonal antibodies, and oligonucleotides, supporting assay development and bioanalytical strategies across different biological matrices. His work provides high-quality bioanalytical data vital for drug discovery and development programs.
Beyond his industry role, Dr. Chakravarty is an Associate Editor for the Network Medicines section of the Journal of Translational Medicine, where he manages peer review and helps advance scientific publishing in translational and interdisciplinary biomedical research. He is also an invited speaker at universities and colleges in India and the United States, engaging with students and academics on the importance of bioanalysis in modern drug development. His professional focus emphasizes scientific rigor, innovation, mentorship, and education, connecting industry practices, scholarly publishing, and scientific outreach in bioanalysis.
Disclosure information not submitted.
Keynote: Beyond Translation: Accelerating Development to Bring Breakthroughs to Patients Faster
Wednesday, May 13, 2026
1:00 PM - 2:00 PM PT